MISSISSAUGA, Ontario, Aug. 19, 2011 /PRNewswire/ — Valeant
Pharmaceuticals International, Inc. (NYSE:
VRX) (TSX: VRX) announced that effective August 19, 2011, the
company completed its previously announced acquisition of AB
Sanitas (NASDAQ OMX: SAN1L).
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of neurology, dermatology and branded
generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Laurie W. Little
949-461-6002
(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)
‘/>”/>
SOURCE